Table 1.
Baseline demographics and characteristics of reflux patients treated with long-term daily maintenance proton pump inhibitor therapy and healthy controls (mean ± SD)
| Patients | Control | P | |
| Number of subjects | 52 | 58 | - |
| Gender (male/female) | 36/16 | 38/20 | NS |
| Age (yr) | 68.1 ± 10.4 | 68.8 ± 1.5 | NS |
| Duration of observation (yr) | NS | ||
| PPI therapy | 2.1 ± 1.1 | - | - |
| Medical checkup | - | 2.0 ± 0.4 | - |
| Body weight (kg) | 56.4 ± 10.4 | 58.6 ± 8.4 | NS |
| Height (cm) | 156.0 ± 9.8 | 156.0 ± 8.9 | NS |
| Body mass index (kg/m2) | 23.1 ± 3.1 | 24.1 ± 2.7 | NS |
| Blood pressure (mmHg) | - | ||
| Systolic | 133 ± 17 | 132 ± 16 | NS |
| Diastolic | 75 ± 11 | 75 ± 9 | NS |
| Serum total protein (g/dL) | 7.2 ± 0.3 | 7.2 ± 0.3 | NS |
| Serum total cholesterol (mg/dL) | 210 ± 39 | 210 ± 25 | NS |
| Serum triglyceride (mg/dL) | 121 ± 52 | 107 ± 43 | NS |
PPI: Proton pump inhibitor.